Combining AstraZeneca’s Covid-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna’s jab provides “good protection”, Denmark’s State Serum Institute said on Aug. 2.
European countries prepared on April 21 to resume deliveries of Johnson & Johnson’s Covid-19 vaccine and speed up the rollout after Europe’s drug regulator backed the shot.
Multiple countries across Europe and parts of Asia suspended the use of AstraZeneca’s Covid-19 vaccine over fears the medication is leading to the development of blood clots in some patients who have received the medication.
Confidence in Covid-19 vaccines is growing, with people’s willingness to have the shots increasing as they are rolled out across the world and concerns about possible side effects are fading, a 14-country survey showed on March 5.
Pfizer slashed in half the volume of Covid-19 vaccines the company will deliver to some EU countries this week, government officials said, as frustration over the U.S. drugmaker’s unexpected cut in supplies grows.
The European Union was asked to allow an extra dose of the Covid-19 vaccine developed by Pfizer and BioNTech to be taken from each vial, a practice allowed elsewhere that would make scarce supplies go further.
Global coronavirus infections exceeded 50 million, according to a Reuters tally, with a second wave of the virus in the past 30 days accounting for a quarter of the total.
Researchers from Aarhus University in Denmark published research indicating that Parkinson’s disease is actually two types of the disease.
Denmark’s Novo Nordisk will cut around 250 jobs in the United States, but the drugmaker will also hire an as-yet undetermined number of staff to new positions.
Novo Nordisk said the world’s top maker of diabetes drugs will lay off 400 staff in Denmark and China as part of a broader restructuring of the company’s research and development organization.